United Therapeutics Corp Annual Shareholders Meeting Transcript
Welcome, everyone, to the 2026 Annual Meeting of Shareholders of United Therapeutics Corporation, which, as you can tell, is being held virtually again this year. Today is, in fact, United Therapeutics' 30th birthday, and we're kicking off our celebrations with this annual meeting.
My name is Paul Mahon, and I'm Executive Vice President, General Counsel, and Corporate Secretary of United Therapeutics. And I'm actually in the room where it happened 30 years ago today, right here where I faxed our articles of incorporation to Delaware exactly at 1 PM on June 26, 1996.
So with the history and the context aside, let's start with some introductions. Those present virtually at this meeting include Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer; James Edgemond, our Chief Financial Officer and Treasurer; and John Hess, our Deputy General Counsel and Assistant Corporate Secretary. Joining us this morning are most of the members of our Board of Directors, including
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

